DKK3 down-regulation has been reported in endometrial cancer (22), lung cancer (23), gastrointestinal cancer (24), breast cancer (25), prostate cancer (26, 27), and renal carcinomas (28). This evidence concerns the gene DKK3 and prostate cancer.